This company has been marked as potentially delisted and may not be actively trading. Intra-Cellular Therapies (ITCI) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Intra-Cellular Therapies (NASDAQ:ITCI)CurrentInstitutional OwnershipPercentage92.33%Number ofInstitutional Buyers(last 12 months)261TotalInstitutional Inflows(last 12 months)$3.07BNumber ofInstitutional Sellers(last 12 months)153TotalInstitutional Outflows(last 12 months)$1.57B Get ITCI Insider Trade Alerts Want to know when executives and insiders are buying or selling Intra-Cellular Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ITCI Institutional Buying and Selling by Quarter Intra-Cellular Therapies Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/18/2025 Voya Investment Management LLC44,125$5.82M0.0%-48.3%0.041% 5/28/2025 Strs Ohio7,355$970K0.0%N/A0.007% 5/21/2025 Geneos Wealth Management Inc.244$32K0.0%+121.8%0.000% 5/21/2025 Bluefin Capital Management LLC10,000$1.32M1.0%N/A0.009% 5/20/2025 Focus Partners Wealth3,214$424K0.0%-8.4%0.003% 5/19/2025 SCS Capital Management LLC72,743$9.60M0.1%N/A0.068% 5/19/2025 UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC284,371$37.51M0.0%-15.2%0.267% 5/16/2025 Woodline Partners LP123,750$16.33M0.1%N/A0.116% 5/16/2025 Arete Wealth Advisors LLC12,117$1.60M0.1%-50.0%0.011% 5/16/2025 Caxton Associates LLP214,783$28.33M1.0%N/A0.202% Get the Latest News and Ratings for ITCI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Intra-Cellular Therapies and its competitors with MarketBeat's FREE daily newsletter. 5/16/2025 Goldman Sachs Group Inc.1,473,764$194.42M0.0%+291.5%1.384% 5/16/2025 Dynamic Technology Lab Private Ltd19,560$2.58M0.4%N/A0.018% 5/16/2025 Twin Securities Inc.440,690$58.14M30.0%N/A0.414% 5/16/2025 PenderFund Capital Management Ltd.1,900$251K0.0%N/A0.002% 5/16/2025 Pentwater Capital Management LP5,190,000$684.67M5.7%N/A4.872% 5/16/2025 Murchinson Ltd.120,049$15.84M0.9%N/A0.113% 5/16/2025 Polar Asset Management Partners Inc.324,020$42.75M1.0%N/A0.304% 5/16/2025 HGC Investment Management Inc.85,800$11.32M4.2%N/A0.081% 5/16/2025 Cinctive Capital Management LP140,000$18.47M1.4%N/A0.131% 5/16/2025 Alliancebernstein L.P.423,171$55.83M0.0%-59.9%0.397% 5/16/2025 Beryl Capital Management LLC541,642$71.45M26.7%N/A0.508% 5/16/2025 AQR Arbitrage LLC252,316$33.29M0.8%N/A0.237% 5/16/2025 AQR Capital Management LLC266,327$35.13M0.0%-50.4%0.250% 5/16/2025 Amundi561,266$74.01M0.0%+20,466.7%0.527% 5/16/2025 Adage Capital Partners GP L.L.C.298,391$39.36M0.1%-56.0%0.280% 5/16/2025 ADAR1 Capital Management LLC48,044$6.34M1.2%N/A0.045% 5/15/2025 Empyrean Capital Partners LP228,000$30.08M1.1%N/A0.214% 5/15/2025 Paulson & CO. Inc.21,500$2.84M0.2%N/A0.020% 5/15/2025 TIG Advisors LLC1,057,892$139.56M8.7%N/A0.993% 5/15/2025 Cubist Systematic Strategies LLC165,377$21.82M0.1%+5.8%0.155% 5/15/2025 Royal Bank of Canada240,601$31.74M0.0%+46.3%0.226% 5/15/2025 Alpine Global Management LLC50,000$6.60M1.7%N/A0.047% 5/15/2025 Vazirani Asset Management LLC25,000$3.30M12.1%N/A0.023% 5/15/2025 Nomura Holdings Inc.14,313$1.89M0.0%N/A0.013% 5/15/2025 Vident Advisory LLC1,586$209K0.0%N/A0.001% 5/15/2025 Magnetar Financial LLC435,715$57.48M0.8%N/A0.409% 5/15/2025 WPG Advisers LLC380$50K0.0%N/A0.000% 5/15/2025 BNP Paribas Financial Markets247,848$32.70M0.0%+485.8%0.233% 5/15/2025 Carlson Capital L.P.23,000$3.03M1.2%N/A0.022% 5/15/2025 Eisler Capital Management Ltd.40,092$5.29M0.0%N/A0.038% REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad)Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!). Click here for the names of our three top stocks to own this year (no purchase necessary).5/14/2025 Ieq Capital LLC36,845$4.86M0.0%+13.7%0.035% 5/14/2025 GABELLI & Co INVESTMENT ADVISERS INC.202,300$26.69M4.1%N/A0.190% 5/14/2025 Gamco Investors INC. ET AL38,100$5.03M0.1%N/A0.036% 5/14/2025 Gabelli Funds LLC325,700$42.97M0.3%N/A0.306% 5/14/2025 Rafferty Asset Management LLC2,484$328K0.0%-41.3%0.002% 5/14/2025 FORA Capital LLC26,176$3.45M0.4%N/A0.025% 5/14/2025 Westchester Capital Management LLC460,267$60.72M3.2%N/A0.432% 5/14/2025 Comerica Bank2,019$266K0.0%-99.0%0.002% 5/14/2025 PSquared Asset Management AG229,086$30.22M22.6%N/A0.215% 5/14/2025 SVB Wealth LLC359$47K0.0%N/A0.000% 5/14/2025 Groupe la Francaise88,438$11.67M0.2%N/A0.083% 5/14/2025 AlphaQuest LLC2,421$319K0.0%-39.2%0.002% 5/14/2025 Van Hulzen Asset Management LLC4,600$607K0.1%-8.0%0.004% 5/14/2025 Compound Planning Inc.2,216$292K0.0%N/A0.002% 5/14/2025 Carmignac Gestion38,819$5.12M0.1%N/A0.036% 5/14/2025 Hsbc Holdings PLC253,660$33.46M0.0%N/A0.238% 5/14/2025 Quantbot Technologies LP13,020$1.72M0.1%N/A0.012% 5/14/2025 Wellington Management Group LLP190,370$25.11M0.0%-81.6%0.179% 5/13/2025 Northern Trust Corp634,535$83.71M0.0%+4.1%0.596% 5/13/2025 Versor Investments LP56,656$7.47M1.2%N/A0.053% 5/13/2025 Algert Global LLC59,701$7.88M0.2%+140.1%0.056% 5/13/2025 State of New Jersey Common Pension Fund D33,199$4.38M0.0%-9.8%0.031% 5/13/2025 American Century Companies Inc.10,773$1.42M0.0%-96.6%0.010% 5/13/2025 Sei Investments Co.191,628$25.28M0.2%-3.1%0.180% 5/13/2025 Kovitz Investment Group Partners LLC2,202$290K0.0%N/A0.002% 5/13/2025 Russell Investments Group Ltd.8,336$1.10M0.0%-74.2%0.008% 5/13/2025 HighTower Advisors LLC3,858$509K0.0%-7.7%0.004% 5/12/2025 Longfellow Investment Management Co. LLC574$76K0.0%N/A0.001% 5/12/2025 Nuveen LLC304,125$40.12M0.0%N/A0.286% 5/12/2025 Invesco Ltd.85,066$11.22M0.0%-97.2%0.080% 5/12/2025 Covestor Ltd1,233$163K0.1%-41.3%0.001% 5/12/2025 Wolverine Asset Management LLC40,265$5.31M0.1%N/A0.038% 5/12/2025 National Bank of Canada FI133,000$17.55M0.0%N/A0.125% 5/12/2025 Swiss National Bank185,200$24.43M0.0%-1.0%0.174% 5/12/2025 Mitsubishi UFJ Asset Management Co. Ltd.268$35K0.0%+152.8%0.000% 5/12/2025 Maryland State Retirement & Pension System4,810$635K0.0%-18.2%0.005% 5/9/2025 Headlands Technologies LLC6,637$876K0.1%-65.2%0.006% 5/9/2025 Deutsche Bank AG693,427$91.48M0.0%-10.6%0.651% 5/9/2025 Chicago Capital Management LLC90,200$11.90M7.4%N/A0.085% 5/9/2025 Charles Schwab Investment Management Inc.895,664$118.16M0.0%-1.2%0.841% 5/9/2025 Vanguard Group Inc.9,519,968$1.26B0.0%-2.1%8.937% 5/9/2025 West Michigan Advisors LLC1,552$205K0.1%N/A0.001% 5/9/2025 ABC Arbitrage SA40,679$5.37M1.0%N/A0.038% 5/9/2025 Cary Street Partners Financial LLC1,500$198K0.0%N/A0.001% 5/9/2025 Sfmg LLC1,748$231K0.0%N/A0.002% 5/9/2025 ING Groep NV376,800$49.71M0.3%+2,914.4%0.354% 5/9/2025 Earned Wealth Advisors LLC1,664$220K0.0%N/A0.002% 5/9/2025 DCF Advisers LLC3,500$462K0.2%-96.5%0.003% 5/9/2025 J. Safra Sarasin Holding AG8,799$1.16M0.0%-71.2%0.008% 5/9/2025 Bank of Nova Scotia11,400$1.50M0.0%N/A0.011% REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad)Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!). Click here for the names of our three top stocks to own this year (no purchase necessary).5/9/2025 PNC Financial Services Group Inc.2,516$332K0.0%-68.7%0.002% 5/8/2025 Commerce Bank2,431$321K0.0%-65.7%0.002% 5/8/2025Jefferies Financial Group Inc.29,909$3.95M0.0%N/A0.028% 5/8/2025 Alberta Investment Management Corp79,000$10.42M0.1%+1,449.0%0.074% 5/8/2025 US Bancorp DE2,195$290K0.0%-39.4%0.002% 5/8/2025 Alpine Associates Management Inc.719,500$94.92M5.0%N/A0.675% 5/8/2025 Vestcor Inc128,319$16.93M0.6%N/A0.120% 5/8/2025 XTX Topco Ltd2,085$275K0.0%N/A0.002% 5/8/2025 GSA Capital Partners LLP7,376$973K0.1%N/A0.007% 5/7/2025 Essex Investment Management Co. LLC49,717$6.56M1.4%-12.6%0.047% (Data available from 1/1/2016 forward) ITCI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ITCI shares? During the previous two years, 419 institutional investors and hedge funds held shares of Intra-Cellular Therapies. The most heavily invested institutionals were Vanguard Group Inc. ($1.26B), FMR LLC ($925.11M), Pentwater Capital Management LP ($684.67M), JPMorgan Chase & Co. ($428.13M), Wasatch Advisors LP ($271.34M), Norges Bank ($268.35M), and Avoro Capital Advisors LLC ($205.47M).Learn more on Intra-Cellular Therapies' institutional investors. What percentage of Intra-Cellular Therapies' stock is owned by institutional investors? 92.33% of Intra-Cellular Therapies' stock is owned by institutional investors. Learn more on ITCI's institutional investor holdings. Which institutional investors have been buying Intra-Cellular Therapies' stock? Of the 354 institutional investors that purchased Intra-Cellular Therapies' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Pentwater Capital Management LP ($5.19M), Norges Bank ($4.41M), Avoro Capital Advisors LLC ($3M), Goldman Sachs Group Inc. ($1.30M), TIG Advisors LLC ($1.06M), Perceptive Advisors LLC ($1.01M), and Raymond James Financial Inc. ($915.36K). How much institutional buying is happening at Intra-Cellular Therapies? Institutional investors have bought a total of 27,073,148 shares in the last 24 months. This purchase volume represents approximately $3.07B in transactions. Which of Intra-Cellular Therapies' major shareholders have been selling company stock? Of the 153 institutional investors that sold Intra-Cellular Therapies' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Invesco Ltd. ($2.99M), GW&K Investment Management LLC ($1.25M), Wellington Management Group LLP ($1.08M), Alliancebernstein L.P. ($785.17K), Wasatch Advisors LP ($599.77K), Principal Financial Group Inc. ($590.79K), and Alyeska Investment Group L.P. ($479.98K). How much institutional selling is happening at Intra-Cellular Therapies? Institutional investors have sold a total of 14,046,974 shares in the last 24 months. This volume of shares sold represents approximately $1.57B in transactions. Related Companies TAK Major Shareholders ARGX Major Shareholders ONC Major Shareholders BNTX Major Shareholders INSM Major Shareholders SMMT Major Shareholders TEVA Major Shareholders GMAB Major Shareholders ASND Major Shareholders RDY Major Shareholders This page (NASDAQ:ITCI) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intra-Cellular Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intra-Cellular Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access